Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Researchers have discovered a virus that could enter human cells in a similar way to COVID-19. But they caution it's much ...

What actually happened was that SARS-CoV-2 began mutating quickly, first to be more transmissible and then to evade our immunity, causing breakthrough infections and reinfections. Five years and ...

A Stanford-led team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is ...

The detection of this highly infectious and transmisisble coronavirus variant 4 years after the first case of SARS-CoV-2 causing COVID-19 was first detected in China's Wuhan city, is a reminder ...

Scientists found that it can bind to human ACE2 receptors, similar to SARS-CoV-2 (the virus behind COVID-19). This suggests it has the potential for animal-to-human transmission. Experts note that ...

PEMGARDA has demonstrated in vitro neutralizing activity against major SARS-CoV-2 variants, including JN.1, KP.3.1.1, XEC, and LP.8.1. PEMGARDA targets the SARS-CoV-2 spike protein receptor ...